The comparative effect of zileuton, a 5-lipoxygenase inhibitor, plus low dose inhaled beclomethasone vs higher dose beclomethasone for asthma

被引：0
|
作者：
OConnor, BJ
Godard, P
Dube, LM
Swanson, LJ
Maki, R
机构：
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1996年 / 97卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：271 / 271
页数：1
相关论文
共 50 条
  • [41] A DOUBLE-BLIND MULTICENTER STUDY OF ZILEUTON, A POTENT 5-LIPOXYGENASE (5-LO) INHIBITOR VERSUS PLACEBO IN THE TREATMENT OF SPONTANEOUS ASTHMA IN ADULTS
    ISRAEL, E
    DRAZEN, J
    PEARLMAN, H
    COHN, J
    RUBIN, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 236 - 236
  • [42] A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings
    Kane, GC
    Pollice, M
    Kim, CJ
    Cohn, J
    Dworski, RT
    Murray, JJ
    Sheller, JR
    Fish, JE
    Peters, SP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (02) : 646 - 654
  • [43] Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose-response study
    Singh, Dave
    Boyce, Malcolm
    Norris, Virginia
    Kent, Sandra E.
    Bentley, Jane H.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2013, 6 : 897 - 903
  • [44] Adrenal function as assessed by low-dose adrenocorticotropin hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled fluticasone propionate
    Niitsuma, T
    Okita, M
    Sakurai, K
    Morita, S
    Tsuyuguchi, M
    Matsumura, Y
    Hayashi, T
    Koshishi, T
    Oka, K
    Homma, M
    JOURNAL OF ASTHMA, 2003, 40 (05) : 515 - 522
  • [45] Low dose inhaled fluticasone propionate administered once daily or twice daily via the Diskus is as safe and effective as beclomethasone dipropionate in steroid naive patients with asthma.
    Selner, J
    Boltansky, H
    Chervinsky, P
    Pearlman, D
    Pedinoff, A
    Weinstein, S
    Wolfe, J
    Stevens, A
    Prillaman, B
    Hamedani, A
    Harding, S
    Field, E
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1319 - 1319
  • [46] Low- vs high-dose inhaled albuterol for the treatment of acute asthma
    Asmus, MJ
    Hendeles, L
    CHEST, 1999, 116 (02) : 585 - 586
  • [47] Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers
    Wong, SL
    Drajesk, J
    Chang, MS
    Witt, G
    Awni, WM
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1998, 19 (03) : 159 - 162
  • [48] Zileuton, a 5-Lipoxygenase Inhibitor, Exerts Anti-Angiogenic Effect by Inducing Apoptosis of HUVEC via BK Channel Activation
    Lim, Hyun-Joung
    Park, Jinbong
    Um, Jae-Young
    Lee, Sang-Seob
    Kwak, Hyun-Jeong
    CELLS, 2019, 8 (10)
  • [49] A placebo controlled comparison of formoterol, montelukast or higher dose of inhaled corticosteroids in subjects with symptomatic asthma despite treatment with low dose inhaled corticosteroids
    Green, RH
    Brightling, CE
    McKenna, S
    Hargadon, B
    Parker, D
    Wardlaw, AJ
    Pavord, ID
    THORAX, 2002, 57
  • [50] Effect of inhibiting the 5-lipoxygenase pathway with montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics
    Allayee, Hooman
    Hartiala, Jaana
    Lee, Won
    Mehrabian, Margarete
    Irvin, Charles
    Conti, David
    Lima, John
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E116 - E117
12345